Cargando…

Potential recruitment into a clinical trial of vascular secondary prevention medications in cerebral small vessel disease, based on concomitant medication use

BACKGROUND: Blood pressure-lowering medications, antiplatelet drugs and statins are often prescribed to asymptomatic patients with white matter hyperintensities (WMH). A clinical trial is needed, but potential trial participants would be excluded if they already had another indication to take the me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morrison, Edward, Lyall, Donald M, Pell, Jill P., Mackay, Daniel F., Doubal, Fergus N., Wardlaw, Joanna M., Quinn, Terence, Makin, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616395/ https://www.ncbi.nlm.nih.gov/pubmed/36324721 http://dx.doi.org/10.1016/j.cccb.2021.100015

Ejemplares similares

Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden
por: Staals, Julie, et al.
Publicado: (2014)

The effect of different combinations of vascular, dependency and cognitive endpoints on the sample size required to detect a treatment effect in trials of treatments to improve outcome after lacunar and non-lacunar ischaemic stroke
por: Makin, Stephen DJ, et al.
Publicado: (2017)

Advanced Neuroimaging of Cerebral Small Vessel Disease
por: Blair, Gordon W., et al.
Publicado: (2017)

Enlarged perivascular spaces and cerebral small vessel disease
por: Potter, Gillian M, et al.
Publicado: (2015)

Clinical management of cerebral small vessel disease: a call for a holistic approach
por: Clancy, Una, et al.
Publicado: (2021)

Small Vessel Disease and Dietary Salt Intake: Cross-Sectional Study and Systematic Review
por: Makin, Stephen D.J., et al.
Publicado: (2017)

Advanced MRI in cerebral small vessel disease
por: van den Brink, Hilde, et al.
Publicado: (2022)

Intracranial hemodynamic relationships in patients with cerebral small vessel disease
por: Blair, Gordon W., et al.
Publicado: (2020)

Clinically Confirmed Stroke With Negative Diffusion-Weighted Imaging Magnetic Resonance Imaging: Longitudinal Study of Clinical Outcomes, Stroke Recurrence, and Systematic Review
por: Makin, Stephen D.J., et al.
Publicado: (2015)

Sex Differences in Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis
por: Jiménez-Sánchez, Lorena, et al.
Publicado: (2021)

Plasma Biomarkers of Inflammation, Endothelial Function and Hemostasis in Cerebral Small Vessel Disease
por: Wiseman, Stewart J, et al.
Publicado: (2015)

The Application of Optical Coherence Tomography Angiography in Cerebral Small Vessel Disease, Ischemic Stroke, and Dementia: A Systematic Review
por: Zhang, Jun-Fang, et al.
Publicado: (2020)

MRI Relaxometry for Quantitative Analysis of USPIO Uptake in Cerebral Small Vessel Disease
por: Thrippleton, Michael J., et al.
Publicado: (2019)

Cerebral Small Vessel Disease and Renal Function: Systematic Review and Meta-Analysis
por: Makin, Stephen D.J., et al.
Publicado: (2015)

Impact of Small Vessel Disease Progression on Long-term Cognitive and Functional Changes After Stroke
por: Clancy, Una, et al.
Publicado: (2022)

Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)
por: Bath, Philip M, et al.
Publicado: (2022)

A Comparison of CVR Magnitude and Delay Assessed at 1.5 and 3T in Patients With Cerebral Small Vessel Disease
por: Stringer, Michael S., et al.
Publicado: (2021)

ESO Guideline on covert cerebral small vessel disease
por: Wardlaw, Joanna M, et al.
Publicado: (2021)

ESO Guideline on covert cerebral small vessel disease
por: Wardlaw, Joanna M, et al.
Publicado: (2021)

Neuropsychiatric symptoms as a sign of small vessel disease progression in cognitive impairment
por: Clancy, Una, et al.
Publicado: (2022)

Retinal capillary microvessel morphology changes are associated with vascular damage and dysfunction in cerebral small vessel disease
por: Wiseman, Stewart J, et al.
Publicado: (2022)

How Much Do Focal Infarcts Distort White Matter Lesions and Global Cerebral Atrophy Measures?
por: Wang, Xin, et al.
Publicado: (2012)

A comparison of location of acute symptomatic vs. ‘silent’ small vessel lesions
por: Valdés Hernández, Maria del C., et al.
Publicado: (2015)

Zooming in on cerebral small vessel function in small vessel diseases with 7T MRI: Rationale and design of the “ZOOM@SVDs” study
por: van den Brink, Hilde, et al.
Publicado: (2021)

Association between Striatal Brain Iron Deposition, Microbleeds and Cognition 1 Year After a Minor Ischaemic Stroke
por: Valdés Hernández, Maria del C., et al.
Publicado: (2019)

Longitudinal Changes of White Matter Hyperintensities in Sporadic Small Vessel Disease: A Systematic Review and Meta-analysis
por: Jochems, Angela C.C., et al.
Publicado: (2022)

Tracer kinetic assessment of blood–brain barrier leakage and blood volume in cerebral small vessel disease: Associations with disease burden and vascular risk factors
por: Stringer, Michael S., et al.
Publicado: (2021)

Protocol: The Lacunar Intervention Trial 2 (LACI-2). A trial of two repurposed licenced drugs to prevent progression of cerebral small vessel disease
por: Wardlaw, Joanna, et al.
Publicado: (2020)

Early life characteristics and late life burden of cerebral small vessel disease in the Lothian Birth Cohort 1936
por: Field, Thalia S., et al.
Publicado: (2016)

Retinal microvasculature and cerebral small vessel disease in the Lothian Birth Cohort 1936 and Mild Stroke Study
por: McGrory, Sarah, et al.
Publicado: (2019)

Interhemispheric characterization of small vessel disease imaging markers after subcortical infarct
por: Valdés Hernández, Maria del C., et al.
Publicado: (2016)

Update on cerebral small vessel disease: a dynamic whole-brain disease
por: Shi, Yulu, et al.
Publicado: (2016)

Retinal arteriolar geometry is associated with cerebral white matter hyperintensities on magnetic resonance imaging
por: Doubal, Fergus N, et al.
Publicado: (2010)

Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions
por: Bath, Philip M., et al.
Publicado: (2015)

Associations of Clinical Stroke Misclassification (‘Clinical-Imaging Dissociation’) in Acute Ischemic Stroke
por: Potter, Gillian, et al.
Publicado: (2010)

Sex differences in the progression of cerebral microbleeds in patients with concomitant cerebral small vessel disease
por: Yoon, Cindy W., et al.
Publicado: (2022)

Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease: The Lacunar Intervention Trial-2 (LACI-2) Randomized Clinical Trial
por: Wardlaw, Joanna M., et al.
Publicado: (2023)

Prevalence and Significance of the Vessel-Cluster Sign on Susceptibility-Weighted Imaging in Patients With Severe Small Vessel Disease
por: Rudilosso, Salvatore, et al.
Publicado: (2022)

Predictors of Lesion Cavitation After Recent Small Subcortical Stroke
por: Gattringer, Thomas, et al.
Publicado: (2019)

Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities
por: Wardlaw, Joanna M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_r11406d8di21k1166erpkf8ec8